Skip to main content
FinSpry Logo
FinSpry
CTKB logo
CTKB
(NASDAQ)
Cytek Biosciences, Inc.
$4.53-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Cytek Biosciences (CTKB) Stock Price & Financial Analysis

Cytek Biosciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.34 - $4.65
52-Week High$6.18
52-Week Low$2.37
Open$4.38
Volume436.52K
Average Volume (3M)436.52K
Market Cap580.59M
Shares Outstanding128.17M
Price to Sales (P/S)2.85
Price to Book (P/B)1.68
EV/EBITDA-32.39
Revenue (TTM)201.49M
Net Income (TTM)-66.54M
Free Cash Flow (TTM)-8.84M
EPS (TTM)$-0.52
Profit Margin-33.02%
Operating Margin-20.04%
Return on Equity (ROE)-19.47%
Debt to Equity0.10
50-Day MA$4.54
200-Day MA$4.31
52-Week Change14.29%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Cytek Biosciences

What is the current stock price for CTKB?

As of the latest trading session, CTKB stock trades at $4.53. The 52-week range is $2.37–$6.18, with a day range of $4.34–$4.65.

What is the P/E ratio for CTKB?

The P/E ratio (Price-to-Earnings) for CTKB is shown in the Key Statistics section. This valuation metric helps compare Cytek Biosciences, Inc. to industry peers.

Does CTKB pay dividends?

Cytek Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CTKB?

Based on 1 analyst, the consensus for CTKB is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CTKB?

Cytek Biosciences's market capitalization is $580.6M, classifying it as a small-cap company. Cytek Biosciences operates in the Healthcare sector within the Medical Devices industry.